Septodont Report issue

For profit Phase 4
Founded: Cambridge ON Canada (1911)
Status: Acquired by Deproco (2000)

Organization Overview

First Clinical Trial
2012
NCT01474382
First Marketed Drug
1972
mepivacaine (carbocaine)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

NOVOCOL HEALTHCARE | NOVOCOL INC | Novocol Pharmaceutical of Canada, Inc. | SEPTODONT | SEPTODONT HOLDING | SEPTODONT INC

Active Ingredients

Marketed Drugs (8)

Key: Septodont (7) Acquired (1)

dyclonine (sucrets) (2018)

epinephrine (levophed) (1980)

levobupivacaine (chirocaine) (2006)

levonordefrin (Neo-Cobefrine) (1976)

lidocaine (xylocaine) (2011)

mepivacaine (carbocaine) (1972)

phentolamine mesylate (regitine) (2008)

prilocaine (citanest) (2010)

Drugs in Phase 4 Trials (1)

Key: Septodont (0) Acquired (1)

phentolamine mesylate (regitine) (5 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 1